STAAR Surgical has submitted data from the European trial of its EVO+ Visian ICL with aspheric optic to DEKRA, the company’s European notified body, according to a press release.
If approved, the lens, which is designed to correct or reduce myopia or hyperopia and presbyopia, could be commercially available in the second quarter of 2020 in countries that recognize the CE mark.
“Our team is pleased to announce our EDOF lens for presbyopia met the primary performance endpoint of our multisite European pivotal clinical trial and that we have recently (Read more...)
Uncategorized